Literature DB >> 17765546

In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D(2)-like dopamine receptors.

Daniela Stark1, Markus Piel, Harald Hübner, Peter Gmeiner, Gerhard Gründer, Frank Rösch.   

Abstract

Benzamide derivatives as radiotracers have played an important role in diagnosing malfunction in dopaminergic neurotransmission. A variety of halogenated and two unsubstituted benzamide derivatives were synthesised and their in vitro affinities to dopaminergic, serotonergic and adrenergic receptors and their lipophilicities were determined. As references IBZM (3), raclopride (4) and FLB457 (5) were tested as well. The two iodinated compounds NAE (27) and NADE (28) displayed K(i) values of 0.68 and 14 nM for the D(2) receptor. The well-established radiotracers FP (1) and DMFP (2) showed affinities in the same range as did the brominated compounds NABrE (29) and NABrDE (30). The log D(7.4) values of 2.91 for NAE (27) and of 2.81 for NADE (28) are in the range of those found for IBZM (3), FP (1) and DMFP (2). These facts allow to expect good properties for the two iodinated compounds NAE (27) and NADE (28) regarding in vivo imaging with SPECT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17765546     DOI: 10.1016/j.bmc.2007.07.017

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.

Authors:  Jogeshwar Mukherjee; Cristian C Constantinescu; Angela T Hoang; Taleen Jerjian; Divya Majji; Min-Liang Pan
Journal:  Synapse       Date:  2015-10-15       Impact factor: 2.562

Review 2.  Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors.

Authors:  Jaromir Myslivecek
Journal:  Life (Basel)       Date:  2022-04-19

3.  Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli.

Authors:  Andrea Kobiella; Sabine Vollstädt-Klein; Mira Bühler; Caroline Graf; Hans-Georg Buchholz; Nina Bernow; Igor Y Yakushev; Christian Landvogt; Mathias Schreckenberger; Gerhard Gründer; Peter Bartenstein; Christoph Fehr; Michael N Smolka
Journal:  Hum Brain Mapp       Date:  2010-05       Impact factor: 5.038

4.  A new multi-gram synthetic route to labeling precursors for the D(2/3) PET agent 18F-fallypride.

Authors:  Kwangho Kim; Nicole R Miller; Gary A Sulikowski; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2008-07-20       Impact factor: 2.823

5.  Synthesis and biological evaluation of 18F-Norfallypride in the rodent brain using PET imaging.

Authors:  Neema Pithia; Neal Gulati; Suresh Pandey; Robert Coleman; Ritu Kant; Jogeshwar Mukherjee
Journal:  Nucl Med Biol       Date:  2013-04-04       Impact factor: 2.408

6.  High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.

Authors:  Nicholas T Vandehey; Jeffrey M Moirano; Alexander K Converse; James E Holden; Jogesh Mukherjee; Dhanabalan Murali; R Jerry Nickles; Richard J Davidson; Mary L Schneider; Bradley T Christian
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-30       Impact factor: 6.200

7.  No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder.

Authors:  D Hernaus; D Collip; Z Kasanova; O Winz; A Heinzel; T van Amelsvoort; S M Shali; J Booij; Y Rong; M Piel; J Pruessner; F M Mottaghy; I Myin-Germeys
Journal:  Transl Psychiatry       Date:  2015-04-14       Impact factor: 6.222

8.  Quantum chemical determination of molecular geometries and spectral investigation of 4-ethoxy-2, 3-difluoro benzamide.

Authors:  V Vidhya; A Austine; M Arivazhagan
Journal:  Heliyon       Date:  2019-11-14

Review 9.  Dopamine receptor mapping with PET imaging in Parkinson's disease.

Authors:  Flavia Niccolini; Paul Su; Marios Politis
Journal:  J Neurol       Date:  2014-03-15       Impact factor: 4.849

10.  Distinguishing Parkinson's disease from atypical parkinsonian syndromes using PET data and a computer system based on support vector machines and Bayesian networks.

Authors:  Fermín Segovia; Ignacio A Illán; Juan M Górriz; Javier Ramírez; Axel Rominger; Johannes Levin
Journal:  Front Comput Neurosci       Date:  2015-11-05       Impact factor: 2.380

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.